ALVRNASDAQHealthcare · Biotechnology

AlloVir, Inc.

$9.81+4.14%(+$0.39)

TickerSpark Score

58/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALVR research report →

52-Week Range11% of range

Low $7.96

Current $9.81

High $24.15

Companywww.allovir.com

Allovir, Inc. , a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus.

CEO: Vikas Sinha CPA,
IPO: 2020
Employees: 6
HQ: Waltham, MA, US

Price Chart

-45.23% · this period

Valuation

Market Cap: $49.48M
P/E: -2.60
P/S: 0.00
P/B: 1.67
EV/EBITDA: -1.25
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -72.78%
ROIC: -46.68%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-43,438,000 · 26.09%
EPS: $-2.85 · 75.70%
Op Income: $-46,152,000
FCF YoY: 43.03%

Performance & Tape

52W High: $24.15
52W Low: $7.96
50D MA: $9.73
200D MA: $14.55
Beta: 0.62
Avg Volume: 22.94K

Get TickerSpark's AI analysis on ALVR

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Feb 21, 25	Sinha Vikas	director, 10 percent owner, officer: See Remarks	sell	303	$3.05K
Feb 21, 25	Hagen Brett R	officer: Chief Accounting Officer	sell	96	$967.277
Feb 21, 25	Miller Edward	officer: General Counsel	sell	106	$1.07K
Jan 23, 25	Miller Edward	officer: General Counsel	sell	47	$444.329
Jan 23, 25	Miller Edward	officer: General Counsel	sell	5	$49.701
Jan 23, 25	Hagen Brett R	officer: Chief Accounting Officer	sell	32	$302.522
Jan 23, 25	Hagen Brett R	officer: Chief Accounting Officer	sell	4	$39.761
Jan 23, 25	Sinha Vikas	director, 10 percent owner, officer: See Remarks	sell	116	$1.10K
Jan 23, 25	Sinha Vikas	director, 10 percent owner, officer: See Remarks	sell	13	$129.223
Jan 10, 25	Miller Edward	officer: General Counsel	sell	409	$180.001